HEVA Dupixent Business Partner Respiratory Diseases

Responsibilities

• Develop and implement US payer-specific HEVA strategy for Dupixent in COPD and Asthma; execute HEVA tactics supporting launch, lifecycle management, commercial objectives, and market access.
• Lead comprehensive US HEVA planning and translate HEVA insights into actionable business strategies; build/maintain cross-functional relationships (commercial, medical, clinical development, market access).
• Set and execute evidence generation priorities and translate Target Value Propositions/market access strategies into evidence hypotheses, requirements, and generation plans.
• Design and execute HEOR/HEVA activities: economic modeling, database/observational research, COA development/validation, systematic literature reviews, evidence synthesis, AMCP dossier development.
• Apply HEOR methods (post-hoc, meta-analysis, indirect treatment comparisons) and disseminate evidence compliantly (e.g., HCEI/PIE).
• Engage external stakeholders (payers, evidence bodies incl. ICER/PDAB/IRA, patient advocacy, conferences); manage vendor/research investments within budget.
• Mentor junior team members and contribute to process improvements.

• Advanced degree (PhD, MD, MS, MPH, or PharmD).
• 5+ years in health economics/outcomes research (or related).
• US product launch experience; strong understanding of US payer evidence/value demonstration.
• Demonstrated HEOR methods expertise (modeling, observational research, evidence synthesis, COA development) and digital/data platform proficiency.

• Dupixent or other respiratory biologics experience.
• Deep COPD/Asthma competitive landscape knowledge;
  Type 2 inflammation biology expertise.

• Healthcare, prevention/wellness programs, and at least 14 weeks’ gender-neutral parental leave.